Institution: | (1) Department of Psychiatry, University of Cambridge School of Clinical Medicine, Addenbrooke’s Hospital, Hills Road, Box 189, CB2 2QQ Cambridge, UK;(2) Behavioral and Clinical Neurosciences Institute (BCNI), University of Cambridge, Cambridge, UK;(3) Department of Experimental Psychology, University of Cambridge, Cambridge, UK;(4) Department of Psychiatry, Queen Elizabeth II Hospital, Welwyn Garden City, Hertfordshire, UK;(5) Postgraduate Medical School, University of Hertfordshire, Hatfield, UK;(6) GlaxoSmithKline, Clinical Unit Cambridge, Cambridge, UK;(7) P1vital Ltd., Oxford, UK |